PhRMA's Tally: $40 Million To Lobby On Health Care
Main Category: Pharma Industry / Biotech IndustryAlso Included In: Health Insurance / Medical Insurance
Article Date: 27 Jul 2009 - 0:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
NPR reports on one of the most powerful players in health care: the Pharmaceutical Research and Manufacturers of America, or PhRMA. In addition to spending $40 million, PhRMA alone has 29 people lobbying for it and has "hired 45 different Washington, D.C., lobbying firms to represent it in those three months of the second quarter."
NPR reports: "It represents just 32 brand-name drug companies, but it has so much influence that when Congress passes a bill, PhRMA almost always gets its way."
"Any firm that spends significant money lobbying Congress has to file a quarterly report. Monday was the deadline for the second quarter, providing a chance to peer into three critical months in the health care debate: April, May and June. That's when Congress really got down to business with health care. In those three months, PhRMA spent just over $6 million, which breaks down to about $2 million a month. But the reports filed by the companies that belong to PhRMA reveal that during this same period, all but a few of them were running their own lobby shops as well."
PhRMA has been advertising and its CEO has been emphasizing the group's support for reform. NPR notes that if you want to see how PhRMA is influencing the debate, look at what issues have been removed from the table, such as drug re-importation from Canada. "This is not to pass judgment on the merits of PhRMA's arguments, but rather to show just how much money and lobbying it uses to back them up - and the winning streak in Congress that follows" (Seabrook and Overby, 7/23).
This information was reprinted from kaiserhealthnews.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery at kaiserhealthnews.org.
© Henry J. Kaiser Family Foundation. All rights reserved.
Visit our pharma industry / biotech industry section for the latest news on this subject.
MLA
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/158826.php>
APA
http://www.medicalnewstoday.com/releases/158826.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



